Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.6M Buy
1,091,385
+231,846
+27% +$6.17M 7.24% 3
2025
Q4
$21.4M Sell
859,539
-392,547
-31% -$9.9M 4.88% 7
2025
Q3
$31.9M Buy
1,252,086
+332,086
+36% +$8.2M 7.91% 1
2025
Q2
$22.3M Sell
920,000
-5,000
-0.5% -$117K 7.29% 1
2025
Q1
$23.4M Sell
925,000
-230,000
-20% -$6.02M 7.51% 2
2024
Q4
$30.6M Buy
1,155,000
+335,000
+41% +$9.09M 10.53% 1
2024
Q3
$23.7M Sell
820,000
-75,000
-8% -$2.19M 7.2% 4
2024
Q2
$25M Sell
895,000
-344,165
-28% -$9.48M 9.36% 2
2024
Q1
$34.4M Buy
1,239,165
+145,749
+13% +$4.04M 9.69% 2
2023
Q4
$31.5M Buy
+1,093,416
New +$33.1M 7.64% 2
2022
Q3
Sell
-100,000
Closed -$5.24M 35
2022
Q2
$5.24M Sell
100,000
-29,738
-23% -$1.52M 1.17% 25
2022
Q1
$6.72M Sell
129,738
-155,665
-55% -$8.08M 1.46% 25
2021
Q4
$16.9M Sell
285,403
-366,197
-56% -$18.1M 3.96% 10
2021
Q3
$28M Sell
651,600
-488,385
-43% -$21.6M 5.59% 2
2021
Q2
$44.6M Sell
1,139,985
-225,778
-17% -$8.78M 7.91% 1
2021
Q1
$49.5M Buy
1,365,763
+772,513
+130% +$27.4M 9.06% 1
2020
Q4
$21.8M Buy
+593,250
New +$21.8M 4.16% 9

Other funds holding PFE

Sector Gamma AS's PFE Position: Q1 2026 in Review

Sector Gamma AS increased its Pfizer (PFE) stake by 27% in Q1 2026, buying an estimated $6.17M and bringing the position to 1,091,385 shares worth $30.6M. The position accounts for 7.24% of the portfolio, ranked #3.

Sector Gamma AS first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. The position peaked at $49.5M in Q1 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sector Gamma AS held 1,091,385 shares of Pfizer worth $30.6M as of Q1 2026.
  • Sector Gamma AS bought 231,846 Pfizer shares in Q1 2026, an estimated $6.17M.
  • Pfizer made up 7.24% of Sector Gamma AS's portfolio in Q1 2026, its #3 holding.
  • Sector Gamma AS first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
  • Sector Gamma AS's Pfizer position peaked at $49.5M in Q1 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.